Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H19N2O.Cl |
| Molecular Weight | 302.799 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CN(C)C1=CC2=C(C=C1)C=C3C=CC(C=C3O2)=[N+](C)C
InChI
InChIKey=INCIMLINXXICKS-UHFFFAOYSA-M
InChI=1S/C17H19N2O.ClH/c1-18(2)14-7-5-12-9-13-6-8-15(19(3)4)11-17(13)20-16(12)10-14;/h5-11H,1-4H3;1H/q+1;/p-1
Pyronin Y is an intercalating dye with a specificity towards RNA. It has been shown to accumulate in the mitochondria of viable cells. Pyronin Y has been used to measure RNA in flow cytometry. Pyronin Y possesses some anti-cancer properties: it causes cell cycle arrest and increases lifespan in a mouse model of sarcoma.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2311222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2428484 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2428484 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2428484
Female C57BL/6 x DBA/2 F1 mice were inoculated with Sarcoma 180 ascites tumor and Pyronin Y (PY) was injected i.p. for 6 days. The dose 15 mg/mouse caused 50% increase in life span.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2428484
The long-term survival (clonogenicity) studies were carried out on CHO cells. Exponentially growing CHO cells were seeded at a concentration of 100 and 1000 cells in Petri dishes. 4h were allowed for cell reattachment before Pyronin Y (PY) was added directly to these cultures to give various concentrations. After incubation for 4 h, the cells were washed 2 times with Hanks' balanced salt solution and refed with a fresh prewarmed medium. Stationary CHO cultures were prepared by growing cells to confluence followed by the addition of fresh medium. After a further 2 days, these cultures were treated with various concentrations of PY for 4 h, trypsinized, washed free of PY, and replated at a concentration of 100 or 1000 cells per plate in drug-free medium. The 4-h exposure of exponentially growing CHO cells to 16.7 UMPY reduced clonogenicity by 50% and exposure to 26.7 uM decreased clonogenicity by 99.9%.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7085
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | |||
|
DTXSID8059051
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | |||
|
W659G165T1
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | |||
|
202-147-8
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | |||
|
m9389
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | Merck Index | ||
|
10454
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | |||
|
92-32-0
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY | |||
|
8682
Created by
admin on Mon Mar 31 18:56:13 GMT 2025 , Edited by admin on Mon Mar 31 18:56:13 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD